Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.2 to v3.6.3, signaling a minor behind-the-scenes update.
    Difference
    0.1%
    Check dated 2026-07-03T20:09:32.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page shows a new revision tag, updating from v3.6.0 to v3.6.2. This reflects a minor backend or rendering update.
    Difference
    0.1%
    Check dated 2026-06-26T20:20:31.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Adds the investigator’s name and new navigation headings, and removes older phrasing and revision notes, reflecting updates to the page’s metadata and user guidance.
    Difference
    2%
    Check dated 2026-06-12T12:46:44.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.5, replacing v3.5.4. This signals a new page version without changes to the study content.
    Difference
    0.1%
    Check dated 2026-06-05T08:25:43.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page shows a new revision number in the footer (v3.5.4) compared with the previous version. The overall study details and content on the page remain the same.
    Difference
    0.1%
    Check dated 2026-05-15T05:48:48.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page footer revision number was updated from v3.5.2 to v3.5.3, indicating a non-content site/version change.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.